// App-Quantinova.ai

2389 : GATA3 Silencing Defines a Distinct Subset of ETP-ALL.

Researchers

Presenter

  • Martin Neumann

Principal Investigators

  • Sandra Heesch

  • Marco Seehawer

  • Cornelia Schlee

  • Liliana H. Mochmann

  • Stefan Schwartz

  • Nicola Goekbuget

  • Dieter Hoelzer

  • Claudia D Baldus

Medical Centers

  • Department of Internal Medicine II, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany

  • Department of Hematology and Oncology, Charite, University Hospital Berlin, Campus Benjamin Franklin, Berlin, Germany

  • Hematology and Oncology, Charite Campus Benjamin Franklin, Berlin, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute Leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • DNA methyltransferase 3 alpha

  • GATA Binding Protein 3

  • DNA methylation

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved